Project Details
| Status | Active |
|---|---|
| Effective start/end date | 9/17/20 → 9/17/26 |
Funding
- Memorial Sloan Kettering Cancer Center ((OE) Prot #NU MSK19H03)
Prot #NU MSK19H03: A Phase II Study of Pembrolizumab and Entinostat in Patients with Relapsed and Refractory Lymphomas (17-073)
- Karmali, Reem (PD/PI)
Project: Research project